V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002354 | 240009518 | 1.8 | 67.5 | Curative (C) | null | 2021-08-28 | FLAIR trial | null | N | IMATINIB | 101399423 |
| 240002374 | 240009521 | 1.75 | 96.5 | Palliative (P) | 2019-08-18 | 2019-08-19 | null | 02 | null | CYTARABINE INTRATHECAL | 100187681 |
| 240002386 | 240009524 | 1.68 | 76.15 | Palliative (P) | 2017-07-26 | 2017-07-27 | null | 02 | null | CISPLATIN + GEMCITABINE | 100377782 |
| 240002389 | 240009525 | 1.56 | 98.9 | Curative (C) | 2020-02-29 | 2020-03-06 | CLADRIBINE | null | null | PEG INTERFERON | 100804433 |
| 240002391 | 240009526 | 1.76 | 41.6 | null | 2019-07-18 | 2019-08-14 | CHOP - 21 days | N | null | INOTUZUMAB OZOGAMICIN | 101179262 |
| 240002392 | 240009527 | 1.15 | 98.5 | Curative (C) | 2019-01-09 | 2019-01-15 | Midostaurin | 02 | N | AML MYECHILD 01 IT CYT | 100607425 |
| 240002393 | 240009528 | 0 | 18.7 | null | 2019-07-02 | 2019-07-09 | null | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE | 100445404 |
| 240002401 | 240009529 | 1.78 | 59.1 | Curative (C) | 2020-10-18 | 2020-10-19 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | 02 | null | ANAGRELIDE | 100808364 |
| 240002403 | 240009530 | 1.77 | 56.9 | null | null | 2019-04-12 | null | null | null | FLAG + IDARUBICIN | 100824587 |
| 240002417 | 240009533 | 1.77 | 30.55 | null | 2019-03-26 | 2019-03-26 | IVE-R | 02 | null | GEMTUZUMAB OZOGAMICIN | 101782255 |
| 240002418 | 240009534 | 1.6 | null | null | 2021-07-12 | 2021-07-13 | R CODOX M | 02 | null | PEG INTERFERON | 100515222 |
| 240002420 | 240009535 | 1.02 | 104.4 | Curative (C) | 2020-05-26 | 2020-06-01 | Triple / Double Intrathecal Therapy + hydrocortisone | 02 | null | CLADRIBINE | 101198817 |
| 240002423 | 240009537 | 1.84 | 76.4 | 03 | 2019-02-16 | 2019-02-16 | FLAIR trial | 02 | N | RUXOLITINIB | 100602549 |
| 240002424 | 240009538 | 1.76 | 45 | null | 2021-10-29 | 2021-11-03 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | MUK 9 TRIAL | 100682624 |
| 240002427 | 240009540 | 1.53 | 70.8 | null | 2019-08-31 | 2019-08-31 | ALL Interim Guide 2019 Capizzi Interim Maintenance C | 01 | null | IMATINIB | 100828896 |
| 240002428 | 240009541 | null | 58 | null | 2016-10-19 | 2016-10-20 | R IVAC | 02 | null | CYTARABINE + DAUNORUBICIN | 101526696 |
| 240002431 | 240009543 | 1.82 | 87.3 | null | null | 2020-05-17 | CODOX M | null | null | AML INTERIM GUIDELINES FLAG-IDA | 101729725 |
| 240002434 | 240009544 | 1.79 | 67.6 | Curative (C) | 2018-06-10 | 2018-06-12 | RUXOLITINIB | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100812746 |
| 240002437 | 240009545 | 1.69 | 84.2 | Curative (C) | 2022-01-26 | 2022-01-30 | null | 02 | N | PEMBROLIZUMAB | 101505664 |
| 240002443 | 240009546 | null | 122.4 | null | 2019-05-29 | 2019-06-08 | ATG + Busulfan + Fludarabine | 02 | null | TRANSPLANT ANTI-THYMOCYTE GLOBULIN + FLUDARABINE + THIOTEPA + TREOSULFAN | 101598345 |
| 240002447 | 240009548 | 1.73 | 122 | null | 2017-07-30 | 2017-08-05 | Triple / Double Intrathecal Therapy | 02 | null | AML MYECHILD | 100679385 |
| 240002448 | 240009549 | 1.73 | 116.7 | Curative (C) | 2016-12-12 | 2019-02-02 | TRANSPLANT ALEMTUZUMAB + CYCLOPHOSPHAMIDE (+/- TBI) | 02 | null | RITUXIMAB + VENETOCLAX | 100616707 |
| 240002449 | 240009550 | 1.53 | 75 | Curative (C) | 2015-09-09 | 2015-10-24 | FLAIR trial | 01 | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 100365555 |
| 240002452 | 240009551 | 1.77 | 22.5 | Adjuvant (A) | 2021-05-07 | 2021-05-07 | null | 02 | N | PEG INTERFERON | 100463616 |
| 240002453 | 240009552 | 1.65 | 106.2 | 03 | 2016-12-04 | 2016-12-04 | null | 02 | N | BRENTUXIMAB | 100564439 |
| 240002460 | 240009556 | null | null | Curative (C) | 2021-06-14 | 2021-06-14 | null | 02 | N | IBRUTINIB | 101381163 |
| 240002472 | 240009558 | 0 | null | Curative (C) | 2021-01-20 | 2021-03-31 | null | 01 | N | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE | 100991995 |
| 240002477 | 240009561 | 0.82 | 0 | null | 2017-02-08 | 2017-02-08 | null | 02 | Y | RUXOLITINIB | 100865088 |
| 240002478 | 240009562 | 1.55 | 63 | 03 | null | 2018-06-10 | AML16 DA 3+10 | null | null | CYTARABINE HIGH DOSE | 100059700 |
| 240002486 | 240009563 | 1.68 | 74 | null | 2018-10-31 | 2019-01-23 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | null | ALCL ALCL 99 CLOSED PRE PHASE | 101706950 |
| 240002487 | 240009564 | 1.51 | 106.6 | null | 2018-08-15 | 2018-08-20 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 02 | null | ACALABRUTINIB | 100475949 |
| 240002489 | 240009565 | 1.85 | null | Curative (C) | 2020-12-15 | 2021-02-25 | AML Interim Guidelines FLA -Ida | 02 | null | IMATINIB | 101869442 |
| 240002492 | 240009566 | 1.91 | 62.8 | Palliative (P) | 2018-05-01 | 2018-05-05 | GEMTUZUMAB OZOGAMICIN | 02 | N | AML MYECHILD 01 HD ARAC | 101353212 |
| 240002497 | 240009568 | 1.61 | 77.8 | Curative (C) | 2021-12-19 | 2021-12-20 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | VENETOCLAX | 101306815 |
| 240002501 | 240009570 | null | null | Curative (C) | 2021-12-14 | 2021-12-14 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 02 | null | CYTARABINE + DAUNORUBICIN | 100078158 |
| 240002520 | 240009573 | 0 | 33.4 | Curative (C) | null | 2021-02-04 | null | null | N | VENETOCLAX | 100018474 |
| 240002522 | 240009574 | 0 | 12.5 | null | 2018-08-16 | 2018-09-23 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | NHL 2003 GP B COP | 100113108 |
| 240002530 | 240009576 | 1.74 | 112.4 | null | null | 2016-03-27 | ALL UKALL2011 Cap Int Maint C PAsp | null | N | AML INTERIM GUIDELINES FLAG-IDA | 101456655 |
| 240002532 | 240009578 | null | 52.5 | Palliative (P) | 2020-02-06 | 2020-02-10 | null | 02 | N | ALL UKALL2011 MAINTENANCE | 100335586 |
| 240002538 | 240009580 | 1.84 | 69 | null | null | 2017-10-08 | GDP | null | null | GEMTUZUMAB OZOGAMICIN | 100878630 |
| 240002539 | 240009581 | 1.64 | 96.4 | Palliative (P) | 2018-12-09 | 2018-12-14 | null | null | N | ETOPOSIDE | 100615225 |
| 240002540 | 240009582 | 1.67 | 68.8 | null | null | 2021-04-24 | LIPOSOMAL DAUNORUBICIN + CYTARABINE (Vyxeos) | 02 | null | AML MYECHILD 01 FLA | 101825739 |
| 240002542 | 240009583 | 1.73 | 77.8 | null | 2021-09-27 | 2021-09-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101652203 |
| 240002543 | 240009584 | 1.64 | 88.3 | 03 | 2020-07-16 | 2020-07-17 | AML MyeChild 01 Triple IT | N | N | BUSULFAN | 100371794 |
| 240002544 | 240009585 | 1.58 | 80.4 | null | null | 2020-12-09 | Alemtuzumab + Cyclophos TBI Allo | N | null | PEG INTERFERON | 100336254 |
| 240002546 | 240009586 | 0 | 67.1 | 03 | 2019-05-24 | 2019-06-04 | null | 02 | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 100372532 |
| 240002553 | 240009588 | 1.6 | 65 | Curative (C) | 2017-05-25 | 2017-05-26 | null | 02 | N | IBRUTINIB | 100040788 |
| 240002563 | 240009590 | 1.59 | 81.4 | null | 2018-09-03 | 2018-09-11 | null | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100236291 |
| 240002565 | 240009591 | 1.78 | 62.8 | Curative (C) | 2018-11-23 | 2018-12-02 | AML MyeChild 01 FLA | 02 | N | ALL UKALL2011 MAINTENANCE | 100932525 |
| 240002566 | 240009592 | 1.77 | 90 | Curative (C) | 2021-09-06 | 2021-09-06 | STS Non-Rhabdo EpSSG 2005 VBL/MTX | 02 | null | INTERFERON ALFA | 101486867 |